Karlo Toljan

MD, PhD, neurologist & neuroimmunologist at the Mellen Center @ClevelandClinic. From 🇭🇷, now in 🇺🇸 Posts=my own

[Karlo Toljan @Karl0CB]

More on 2024 MS diagnostic criteria at the Mellen Update 2025:
@DanOntaneda
provided an overview, while I presented the application. +other excellent lectures from the same event
@mssociety @ACTRIMS @ECTRIMS
#MultipleSclerosis LINK https://t.co/oIVZYCzJTC

[Karlo Toljan @Karl0CB]

Thankful and lucky for all the collaborators, supporters, and excellent mentorship, which led to final manifestation of this dissertation. 🍀🍀

[Daniel Ontaneda @DanOntaneda]

Congratulations to @Karl0CB for a successful defense of his PhD. An honor to be his advisor. Getting a PhD in Residency and Fellowship is no small feat 5 papers will come from his thesis. Important work that helped get CVS in DXcriteria @ClevelandClinic @BlakeBuletko @CLENeurons

[Daniel Ontaneda @DanOntaneda]

Very nice work by @Karl0CB and the entire CAVS-MS team @PascalSati @takishinohara @danielsaloreich We will see similar results from @nikosevangelou3 and DECISIVE soon! This data was used to get CVS into the McDonald criteria!

[Karlo Toljan @Karl0CB]

Standing on the shoulders of the team, and mostly on my mentor's @DanOntaneda Hope I'm not too heavy ;) The way to go is CVS and PRL!

[Daniel Ontaneda @DanOntaneda]

Congratulations to @Karl0CB for receiving an award at our NI CCF training day @CLENeurons @ClevelandClinic important work on central vein and paramagnetic rims. Couldn’t be prouder! Congrats! Special thanks to collaborators @PascalSati @danielsaloreich @takishinohara

[Cleveland Clinic MD @CleClinicMD]

New studies point to potential for greater reliance on objective imaging biomarkers for accurate diagnosis of multiple sclerosis: https://t.co/whGjU8lVCW

[Karlo Toljan @Karl0CB]

@tim_coetzee @MarisaMcginley and VIRTUAL-MS expanding with a trial based on telehealth in MS https://t.co/3ZCWfm90t3

[Karlo Toljan @Karl0CB]

@ajlees @InstitutCerveau @michael_zandi @FacultyHP @UCLIoN @jonstoneneuro @AlanCarson15 Writers came from Gogol’s overcoat, neurologists from Charcot

[Karlo Toljan @Karl0CB]

@GavinGiovannoni Of note, in this recent Swedish retrospective NS cohort, definite NS was associated with 7/14 having positive OCB. https://t.co/uMCD34hCLQ

[Karlo Toljan @Karl0CB]

@maryannmays11 @BlakeBuletko @DanOntaneda 14 + 2 book chapters

[Karlo Toljan @Karl0CB]

Tools of the trade!
Last official day of residency at @CLENeurons @ClevelandClinic
Looking back at some numbers over 2 senior years; patients I have encountered during inpatient rotations:

[Karlo Toljan @Karl0CB]

Thanks to many teachers and colleagues at Main: @BlakeBuletko @maryannmays11

Ready for fellowship across the street at Mellen! @DanOntaneda

[Karlo Toljan @Karl0CB]

- nights: 201
- acute stroke: 177
- 24h call: 117
- consult: 111
- gen neuro: 84
- stroke: 61
- neurohospitalist: 59
- NICU: 55
- epilepsy: 54
- pediatric: 35
= 954

+ as a moonlighter: 139
+ many more in clinic and as a jr resident

[Karlo Toljan @Karl0CB]

MSTU going strong through ice, snow, and winds during holidays, and the team ready in house❄️🚑🧠 @CLENeurons @shazamhussain @BlakeBuletko @andrewrussman

[Karlo Toljan @Karl0CB]

Privilage to work with the group and @DanOntaneda as primary mentor. More ahead! Qualitative, not just quantitative, neuroimaging biomarkers in #MultipleSclerosis @ECTRIMS @ACTRIMS @mssociety

[Daniel Ontaneda @DanOntaneda]

This was excellent work done by @Karl0CB in the NAIMS CAVS-MS pilot team effort with @PascalSati @takishinohara @danielsaloreich and Andy Solomon. Also our prospective multi center study is fully enrolled!

[Karlo Toljan @Karl0CB]

@CCalabreseDO @AdamJBrownMD @HealioRheum @ELittlejohnDO @LCalabreseDO And Venice adopted it from their neighbor-competitor, Republic of Ragusa (city of Dubrovnik, known as GoT King’s Landing filming location most recently) https://t.co/Ufm8QzCBcQ

[Karlo Toljan @Karl0CB]

@FBarkhof @OliviaWills20 @J_SastreGarriga Personalized or precision?

[Karlo Toljan @Karl0CB]

@OliviaWills20 @J_SastreGarriga Does pharmacogenetics belong to the left column only or also to the right? Can it be personalized + a bit ‘precise’?

[Karlo Toljan @Karl0CB]

PwMS as primary beneficiaries of MS research. Understanding information as empowerment. HT to organizers @MarTintore and @DanOntaneda among panelists @mssociety @mssocietyuk @MSSocietyCanada #MultipleSclerosis

[ECTRIMS @ECTRIMS]

This year ECTRIMS is ensuring the latest MS research unveiled at our congress reaches the entire #MS community. The ECTRIMS 2022: For People with MS Event is now available for viewing in English, Dutch, French, German, Italian & Spanish.

Watch it now ➡️ https://t.co/GHq9cP6aiY

[Karlo Toljan @Karl0CB]

@LCalabreseDO @RulaHajjAliMD @MaxKonigMD @CCalabreseDO @EBRheum Eculizumab is also effective for NMO https://t.co/RHwaXUk2gX

[Karlo Toljan @Karl0CB]

@PTenigma @nsanar @ycgyan @ajlees AD as imaging disease?!